Cao Y - Search Results

1

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.

Cao Y. Cao Y. Nat Rev Drug Discov. 2010 Feb;9(2):107-15. doi: 10.1038/nrd3055. Nat Rev Drug Discov. 2010. PMID: 20118961 Review.

2

Vascular endothelial growth factor C induces angiogenesis in vivo.

Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi JH, Claesson-Welsh L, Alitalo K. Cao Y, et al. Among authors: cao r. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14389-94. doi: 10.1073/pnas.95.24.14389. Proc Natl Acad Sci U S A. 1998. PMID: 9826710 Free PMC article.

3

Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.

Cao R, Wu HL, Veitonmäki N, Linden P, Farnebo J, Shi GY, Cao Y. Cao R, et al. Among authors: cao y. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5728-33. doi: 10.1073/pnas.96.10.5728. Proc Natl Acad Sci U S A. 1999. PMID: 10318952 Free PMC article.

4

Therapeutic potentials of angiostatin in the treatment of cancer.

Cao Y. Cao Y. Haematologica. 1999 Jul;84(7):643-50. Haematologica. 1999. PMID: 10406908 Review.

5

Interleukin-18 acts as an angiogenesis and tumor suppressor.

Cao R, Farnebo J, Kurimoto M, Cao Y. Cao R, et al. Among authors: cao y. FASEB J. 1999 Dec;13(15):2195-202. doi: 10.1096/fasebj.13.15.2195. FASEB J. 1999. PMID: 10593867

These results suggest that IL-18 may participate in the regulation of a switch of tumor angiogenesis.-Cao, R., Farnebo, J., Kurimoto, M., Cao, Y. Interleukin-18 acts as an angiogenesis and tumor suppressor....

These results suggest that IL-18 may participate in the regulation of a switch of tumor angiogenesis.-Cao, R., Farnebo, J., Kurimoto, …

6

Endogenous angiogenesis inhibitors and their therapeutic implications.

Cao Y. Cao Y. Int J Biochem Cell Biol. 2001 Apr;33(4):357-69. doi: 10.1016/s1357-2725(01)00023-1. Int J Biochem Cell Biol. 2001. PMID: 11312106 Review.

7

Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes.

Bråkenhielm E, Cao R, Cao Y. Bråkenhielm E, et al. Among authors: cao r, cao y. FASEB J. 2001 Aug;15(10):1798-800. doi: 10.1096/fj.01-0028fje. FASEB J. 2001. PMID: 11481234 No abstract available.

8

Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.

Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, Fleet C, Tritsaris K, Dissing S, Leboulch P, Cao Y. Eriksson A, et al. Among authors: cao r, cao y. Cancer Cell. 2002 Feb;1(1):99-108. doi: 10.1016/s1535-6108(02)00028-4. Cancer Cell. 2002. PMID: 12086892

9

Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.

Eriksson A, Cao R, Roy J, Tritsaris K, Wahlestedt C, Dissing S, Thyberg J, Cao Y. Eriksson A, et al. Among authors: cao r, cao y. Circulation. 2003 Mar 25;107(11):1532-8. doi: 10.1161/01.cir.0000055324.34758.32. Circulation. 2003. PMID: 12654612

10

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2.

Cao R, Bråkenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y. Cao R, et al. Among authors: cao y. Nat Med. 2003 May;9(5):604-13. doi: 10.1038/nm848. Epub 2003 Mar 31. Nat Med. 2003. PMID: 12669032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results